MDAI vs. SRTS, ZJYL, LNSR, PDEX, ECOR, TELA, FONR, STIM, MGRM, and MLSS
Should you be buying Spectral AI stock or one of its competitors? The main competitors of Spectral AI include Sensus Healthcare (SRTS), Jin Medical International (ZJYL), LENSAR (LNSR), Pro-Dex (PDEX), electroCore (ECOR), TELA Bio (TELA), FONAR (FONR), Neuronetics (STIM), Monogram Orthopaedics (MGRM), and Milestone Scientific (MLSS). These companies are all part of the "medical equipment" industry.
Spectral AI vs.
Spectral AI (NASDAQ:MDAI) and Sensus Healthcare (NASDAQ:SRTS) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, earnings, institutional ownership, risk, dividends, media sentiment, valuation, profitability and community ranking.
Spectral AI has a beta of 0.41, indicating that its share price is 59% less volatile than the S&P 500. Comparatively, Sensus Healthcare has a beta of 1.24, indicating that its share price is 24% more volatile than the S&P 500.
Sensus Healthcare received 178 more outperform votes than Spectral AI when rated by MarketBeat users. However, 100.00% of users gave Spectral AI an outperform vote while only 68.54% of users gave Sensus Healthcare an outperform vote.
Sensus Healthcare has higher revenue and earnings than Spectral AI. Spectral AI is trading at a lower price-to-earnings ratio than Sensus Healthcare, indicating that it is currently the more affordable of the two stocks.
Spectral AI currently has a consensus target price of $4.75, indicating a potential upside of 130.58%. Sensus Healthcare has a consensus target price of $14.33, indicating a potential upside of 145.43%. Given Sensus Healthcare's higher probable upside, analysts plainly believe Sensus Healthcare is more favorable than Spectral AI.
Sensus Healthcare has a net margin of 15.90% compared to Spectral AI's net margin of -40.78%. Sensus Healthcare's return on equity of 12.60% beat Spectral AI's return on equity.
In the previous week, Sensus Healthcare had 8 more articles in the media than Spectral AI. MarketBeat recorded 9 mentions for Sensus Healthcare and 1 mentions for Spectral AI. Sensus Healthcare's average media sentiment score of 0.09 beat Spectral AI's score of 0.00 indicating that Sensus Healthcare is being referred to more favorably in the news media.
67.1% of Spectral AI shares are held by institutional investors. Comparatively, 25.3% of Sensus Healthcare shares are held by institutional investors. 56.7% of Spectral AI shares are held by insiders. Comparatively, 9.4% of Sensus Healthcare shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
Summary
Sensus Healthcare beats Spectral AI on 14 of the 18 factors compared between the two stocks.
Get Spectral AI News Delivered to You Automatically
Sign up to receive the latest news and ratings for MDAI and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Spectral AI Competitors List
Related Companies and Tools
This page (NASDAQ:MDAI) was last updated on 2/8/2025 by MarketBeat.com Staff
Free MDAI Stock Alerts